These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12015935)

  • 21. Usefulness of abciximab for treatment of early coronary artery stent thrombosis.
    Casserly IP; Hasdai D; Berger PB; Holmes DR; Schwartz RS; Bell MR
    Am J Cardiol; 1998 Oct; 82(8):981-5. PubMed ID: 9794358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty.
    Lee CW; Moon DH; Hong MK; Lee JH; Choi Si; Yang HS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2002 Dec; 90(11):1243-6. PubMed ID: 12450607
    [No Abstract]   [Full Text] [Related]  

  • 23. Accessibility of abciximab to megakaryocytes and endothelial cells in the bone marrow compartment: studies on a patient receiving antithrombotic therapy.
    Poujol C; Durrieu-Jais C; Larrue B; Nurden AT; Nurden P
    Br J Haematol; 1999 Dec; 107(3):526-31. PubMed ID: 10583253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive therapies in the cath lab. Successful thrombolysis using the combination of tissue plasminogen activator and abciximab in an adult with Kawasaki's disease.
    Chandwaney RH; Stathopoulos T; Sunew J; McPherson D; Davidson CJ
    J Invasive Cardiol; 2001 Sep; 13(9):651-3. PubMed ID: 11533505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy.
    Gibson CM; de Lemos JA; Murphy SA; Marble SJ; McCabe CH; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2001 May; 103(21):2550-4. PubMed ID: 11382722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravascular ultrasound and angiographic demonstration of left main stem thrombus-high-risk presentation in a young adult with anabolic steroid abuse.
    Garg P; Davis G; Wilson JI; Sivananthan M
    Am Heart Hosp J; 2010; 8(2):E125-7. PubMed ID: 21928180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of coronary artery perforation in patients receiving abciximab.
    Del Campo C; Zelman R
    Catheter Cardiovasc Interv; 2001 Sep; 54(1):139-40. PubMed ID: 11553964
    [No Abstract]   [Full Text] [Related]  

  • 28. Routine use of abciximab in coronary stenting?
    Stables RH
    Lancet; 1998 Jul; 352(9122):81-2. PubMed ID: 9672267
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation.
    Henry P; Boughalem K; Rinaldi JP; Makowski S; Khalife K; Guermonprez JL; Blanchard D
    Cathet Cardiovasc Diagn; 1998 Jan; 43(1):105-7. PubMed ID: 9473205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Day-case transfer for percutaneous coronary intervention with adjunctive abciximab in acute coronary syndromes.
    Blackman DJ; Clarke NR; Orr WP; Wilkinson E; Beswick A; Coppock D; Sprigings DC; Banning AP
    Heart; 2002 Apr; 87(4):375-6. PubMed ID: 11907016
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty.
    Ochała A; Smolka G; Wojakowski W; Gabrylewicz B; Garbocz P; Tendera M
    Kardiol Pol; 2007 Jun; 65(6):672-80; discussion 681-3. PubMed ID: 17629829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute platelet inhibition with abciximab does not reduce in-stent restenosis.
    Ikeda U; Hojo Y; Katsuki T; Shimada K
    Circulation; 2000 Oct; 102(15):E110. PubMed ID: 11023951
    [No Abstract]   [Full Text] [Related]  

  • 33. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. An industry perspective on health economics studies.
    Anderson KM; Bala MV; Weisman HF
    Am Heart J; 1999 May; 137(5):S129-32. PubMed ID: 10220615
    [No Abstract]   [Full Text] [Related]  

  • 34. Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention.
    Kereiakes DJ
    Circulation; 2000 Dec; 102(25):E186. PubMed ID: 11120710
    [No Abstract]   [Full Text] [Related]  

  • 35. Stent procedure complicated by thrombus formation distal to the lesion within a muscle bridge.
    Agirbasli M; Hillegass WB; Chapman GD; Brott BC
    Cathet Cardiovasc Diagn; 1998 Jan; 43(1):73-6. PubMed ID: 9473197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monoclonal antibodies in cardiology].
    Legrand V
    Rev Med Liege; 2009; 64(5-6):310-2. PubMed ID: 19642465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
    Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
    Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts.
    Barsness GW; Buller C; Ohman EM; Schechter E; Pucillo A; Taylor MA; Miller MJ; Reiner JS; Churchill D; Chandler AB; Gonzalez M; Smith J; Tommaso C; Berdan LG; Wildermann NM; Hasdai D; Holmes DR
    Am Heart J; 2000 May; 139(5):824-9. PubMed ID: 10783216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus.
    Robinson N; Barakat K; Dymond D
    Heart; 1999 Apr; 81(4):434-7. PubMed ID: 10092575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiographic predictors of adverse outcomes in the modern interventional era.
    White CJ
    J Am Coll Cardiol; 2003 Sep; 42(6):989-90. PubMed ID: 13678917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.